Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...
About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determining the best dose for a cancer drug combination in clinical trials.The co ...
Indaptus Therapeutics (INDP) announced that it has advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. This expansion ...
Real-Time Innovations (RTI) is the infrastructure software company for smart-world systems. RTI Connext ® is the world's leading software framework for intelligent distributed systems. Uniquely, ...
Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of ...
This week's Targeted Pulse highlights immunotherapy’s success in triple-negative breast cancer and key FDA actions shaping treatment advancements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback